Two common single nucleotide polymor phisms (SNPs) within the COL1A1 gene and the C677T variant within the methylenetetrahydrofolate re ductase (MTHFR) gene have been studied for correlation with bone mineral density (BMD) in 126 postmenopausal Maltese women (55.6 ± 7.1 years). All polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), while BMD at the lumbar spine (LS), femoral neck (FN), Ward's triangle and tro chanter was measured by dual energy X-ray absorpti ometry (DEXA).
INTRODUCTION
The search for genes responsible for most complex diseases is a challenging task in human genetics since these diseases result from complex interactions between the environment and susceptibility alleles in multiple genes. Several single nucleotide polymorphism (SNPs) within candidate genes have been studied for association with increased susceptibility to osteoporosis and/or fracture risk [1, 2] . These candidate genes are primarily involved in biological processes of bone physiology and include genes for various receptors [3] [4] [5] [6] , cytokines [7] , growth factors [8] [9] [10] and structural proteins [11] . Genes not directly involved in bone biology have also been stud ied [12, 13] .
Type I collagen is the most abundant and ubiquitously expressed of the collagen superfamily of proteins that are the most abundant proteins in the human body. Genes that encode the α1(I) and α2(I) chains are located on chromo somes 17 and 7, respectively, and several polymorphisms and mutations have been identified and associated with diseases such as osteogenesis imperfecta and osteoporosis [14, 15] . In 1996, a novel polymorphism in the Sp1 binding site of the COL1A1 gene promoter was associated with low bone mass and increased risk of vertebral fracture [11] . Similar studies in other populations produced con flicting results [16] [17] [18] [19] [20] [21] . Two new polymorphisms in the regulatory region of the COL1A1 gene, to which primary osteoblast nuclear proteins bind, were recently identified, of which a G→T transversion at position -1997 was asso ciated with decreased lumbar bone mineral density (BMD) and to a lesser degree, with femoral BMD in postmeno pausal women [22] .
Collagen undergoes several posttranslational modifica tions which include cross-linking and hydroxylation of proline and lysine residu es, catalyzed by various isom erases and hydroxylases [15] . High serum homocysteine concentra tions may interfere with cross-linking of colla gen and thus affect bone quality [23] . Such in crea sed concen trations have been observed in individuals with a low folate status who are homozygous for the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene [24] in which substitution from alanine to valine produces a thermolabile enzyme [25] . This common variant has been associated with coronary artery disease [25] , neural tube defects [26] and low bone BMD [12, 27] . Suggestive linkage of femoral BMD has been reported to locus 1p36 [28] [29] [30] , where the MTHFR and other candidate genes for osteoporosis are located [13] . We have studied the Sp1 and -1997 G→T polymorphisms within the promoter region of the COL1A1 gene and the MTHFR C677T vari ant for association with BMD in a group of postmenopausal women in Malta.
MATERIALS AND METHODS
Patient Recruitment. One hundred and twentysix postmenopausal women were recruited from new subjects referred to the Bone Density Unit, Department of Obstet rics and Gynaecology, St. Luke's Hospital, G'Mangia, Malta, for an osteoporosis risk evaluation. All were healthy Caucasians between the ages of 40-75 years [mean ± standard deviation (SD): 55.6 ± 7.1 years]. Informed consent was obtained from all participants and the study was approved by the Research Ethics Committee of the Faculty of Medicine and Surgery, University of Malta, Msida, Malta. All participants answered a detailed questionnaire concerning medical conditions and the use of medications, family history of osteoporosis and dietary/ lifestyle habits, and only those with no medical conditions and not on treatments known to affect bone metabolism, were included. Blood for DNA analysis and biochemical markers of bone turnover was collected from each partici pant.
According to World Health Organization (WHO) cri teria [31] for both lumbar and femoral BMD, 30 (24.4%) of the participants were osteoporotic at the lumbar spine (LS) (t-score < -2.5), 41 (33.3%) were osteopenic ( t-score < -1.0 to -2.5) and 52 (42.2%) were normal. At the femo ral neck (FN), four (3.2%) were osteoporotic, 45 (36.3%) osteopenic and 75 (60.5%) were normal. The sample was divided into two groups, one of normal individuals (41.1%) having both lumbar and femoral t-score > -1.0 and another of individuals who were osteopenic and/or osteo porotic at one or both anatomical sites (58.9%). The MTHFR C677T polymorphism was also analyzed in a random sample of 254 cord blood DNA obtained from neonates to determine the frequency of this polymorphism in the Maltese population at birth.
Genetic Analysis. Genomic DNA was extracted and purified from peripheral blood leucocytes by the salting-out procedure [32] . Fragments within the COL1A1 and MTHFR genes were amplified by polymerase chain reac tion (PCR), using appropriate primers as previously described [11, 12, 22] . All reactions were performed in a total volume of 25 mL where amplification was performed using a 'hot-start' PCR protocol for the COL1A1 Sp1 and MTHFR C677T polymorphisms. Amplification of the COL1A1 -1997 G→T fragment was done using a hot-start/touchdown protocol starting from an annealing tem perature of 60°C decreasing by 1°C every two cycles until it reached 50°C, followed by 15 cycles at an annealing temperature of 53°C. The correct size of the amplified products was evaluated by electrophoresis of 5 µL PCR product on a 1.0% agarose gel. The PCR products (10 µL) were digested using the restriction enzymes MscI (COL1A1 Sp1), BsaI (COL1A1 -1997 G→T) and HinfI (MTHFR C677T) according to the manufacturer's instructions (New England Biolabs, Beverly, MA, USA). Nomen clature used for the COL1A1 -1997 G→T and MTHFR C677T refers to the actual nucleotide changes in the respective polymorphisms. Since the same nucleotide changes occur in both COL1A1 -1997 G→T and Sp1 polymorphisms, the Sp1 variant was labeled SS→Ss→ss (for nucleotide changes GG→GT→TT). Re-analysis of 20% of samples was performed to check for accuracy of COL1A1 AND MTHFR GENES AND BMD genotyping. No discrepancies were found from the original genotyping.
Biochemical Markers of Bone Turnover. Blood and urine samples were collected and analyzed for biochemical markers of bone turnover. Urinary deoxypyridinoline (DpD) crosslinks and serum procollagen type I were used as markers of bone resorption and formation, respectively (Metra Biosystems Inc., San Diego, CA, USA).
Bone Densitometry. Bone mineral density was meas ured at the LS (L2-L4) and FN using a Norland 486 Dual-Energy X-ray Absorptiometer (Norland Medical Systems Inc., New York, NY, USA). The BMD measurements were done at the Bone Density Unit, St. Luke's Hospital, G'Mangia, Malta.
Statistical Analysis. The normality of the population was tested using the non parametric Kolmogorov-Smirnov test. The chi-square test was used to test for Hardy-Wein berg and for differences in genotype frequencies between normal individuals and those with low BMD. Comparisons of continuous measurements were performed using the one-way analysis of variance (ANOVA), independent sample t-test or alternatively, the Kruskal-Wallis and MannWhitney tests were used for those variables not showing a normal distribution. Adjustments for age, body mass index (BMI) and years since menopause (YSM) were performed using a generalized linear model (GLM) uni variate analysis of variance. Linear regression was used to test for allele dose effect. All statistical tests were per formed using the Statistical Package for Social Sciences (SPSS) for Windows, student version 9.0 (SPSS, Chicago, IL, USA). The EH software by Terwillinger and Ott [33] was used to construct haplotypes of polymorphisms within the COL1A1 gene, to test for association between alleles (linkage disequilibrium) and for association of haplotypes with low BMD by comparing normal women with those who had a low BMD.
RESULTS

COL1A1
Genotypes. The distributions of the COL1A1 Sp1 and -1997 G→T genotypes in postmeno pausal women are shown in Tables 1 and  2 , respectively; both were shown to be in Hardy- (Tables 1 and 2 ). Statistical significance was not reached on tests for genetic models of a dominant or reces sive allele (Table 3) or for an allele dose effect by linear regression (p >0.05) (data not shown).
MTHFR C677T Polymorphism. The genotype fre quencies for the MTHFR C677T polymorphism observed in postmenopausal women are shown in Table 4 . Allele frequencies observed were 63.9% for the C allele and 36.1% for the T, yielding a calculated heterozygosity rate of 46.3%.
The LS, FN, trochanter and Ward's triangle BMD were lowest in CC homozygotes, although the differences between the genotypes did not reach statistical signifi cance (p >0.05) ( Table 4 ). The C allele was significantly correlated with trochanter BMD and, to a lesser degree, with FN BMD (Table  5) . No allele dose effect was observed at any anatomical site for the same allele (p >0.05).
There were no differences in the distribution of geno type frequencies of both COL1A1 polymorphisms between normal postmenopausal women (independent sample t-score > -1.0) and those with a low LS and/or FN BMD when tested by chi-square (p >0.05) ( Table 6 ). Haplotype frequencies were not statistically significant when com pared between these two groups (χ2 = 1.14; p = 0.76; df = 3) ( Table  6 ). The MTHFR C677T genotype frequencies did not differ significantly between the normal women and those with a low BMD (χ2 = 0.78; p = 0.68; df = 2) ( Table 6 ).
The MTHFR C677T Frequency in the Maltese Population at Birth. In neonates (n = 245), COL1A1 AND MTHFR GENES AND BMD genotype frequencies for this polymorphism were 46.1% CC, 43.3% CT and 10.6% TT and were in Hardy-Weinberg equilib rium (χ2 = 0.02; p = 0.88; df = 1).
DISCUSSION
Genotype frequencies observed for the -1997 G→T polymorphism in our group of postmenopausal women were similar to those reported from Spain [22] . Those for the Sp1 polymorphism were closer to those in two South ern European populations [20, 34] than in other Caucasians [11, 16, 22, [35] [36] [37] . The Sp1 polymorphism is absent in Asian populations [38, 39] .
For the Sp1 polymorphism the highest LS BMD was found in SS homozygotes, while the influence on FN BMD was minimal but the differences did not reach signifi cance for both sites. This trend agrees with that reported by Garnero and co-workers [40] who found SS homozy gotes to have the highest and statistically significant LS BMD, but no association with FN BMD. An influence of Sp1 polymorphism on LS BMD was observed by others [11, 35] and also an association with FN BMD [37] . Other investigators did not find the Sp1 polymorphism to affect BMD [21, 22] or found it to be associated with an increased fracture risk at the LS, FN and other skeletal sites [17, 20, 36] . The increased risk of fracture at the FN has been explained by differences in FN geometry between different genotypes [41] .
Our results for the -1997 G→T SNP differed from those observed in Spain [22] , where the lowest BMD was found in TT, and not in GG homozygotes, in contrast to our results. As reported COL1A1 AND MTHFR GENES AND BMD At the phenotypic level, these polymorphisms can be influenced by interactions with other genes and with vari ous environmental factors. We analyzed a common C677T polymorphism within the MTHFR gene for any correlation with BMD and found that TT homozygotes had the high est, but not statistically significant BMD at all anatomical sites, and that the C allele had a negative effect on trochanter BMD. This contrasts with what was reported on Japa nese women where the T allele was associated with low BMD [27] . However, in a Danish study the T allele was associated with a decreased risk of fractures independently of BMD [12] . A degree of genotypic and allelic variations exist among ethnic groups such that there is a higher prev alence of TT homozygotes in southern European popu lations, Hispanics and Mexicans [44] . The frequency of TT homozygotes we observed is similar to that reported for Spanish, French [44] and Portuguese [45] populations, but lower than that for Italians [44] and Japanese [27], and higher than that for northern Europeans [12, 44] .
One reason for these conflicting results may be differ ences in folate intake in these populations. Recently, TT homozygotes were found to be associated with low BMD only in the presence of low plasma folate concentration, whereas the highest femoral and trochanter BMD were found when plasma folate concentrations were above 4 ng/ mL [24] . It has been suggested that the north-south increase in the prevalence of TT homozygotes may be influenced by the higher folic acid content of the Mediter ranean diet [46] . Low plasma folate may result in hyper homocysteinemia, independently of the C677T polymor phism [47] . Levels of riboflavin and vitamins B 12 and B 6 also modify the effect of the MTHFR TT genotype on BMD in the Danish population, although it was estimated that only 2% of the population will benefit from vitamin B supplementation [48] .
The C677T SNP may also be influenced by nearby polymorphisms that are in linkage disequilibrium with the C677T SNP, an example being the 1298A→C that is known to affect plasma homocysteine levels [45] . Differ ent phenotypic expression of this polymorphism might be affected by other variants within nearby genes on the same candidate region 1p36 [13, 9] , as well as by genes coding for enzymes involved in the same metabolic pathway as methionine synthase reductase and cystathionine synthase. The C677T polymorphism in the MTHFR gene is also known to affect DNA methylation, which is a major epi genetic controller of gene expression. It has been reported that TT homozygotes had a diminished level of DNA methylation when compared to CC homozygotes only when folate levels were low [49] .
We found no association between two COL1A1 gene variants and an increased risk for low BMD in Maltese postmenopausal women. It is clear that allelic heterogene ity exists between different populations, and that different genes and gene variants may be responsible for osteopo rosis in different ethnic groups. Future studies should focus on gene expression and how this may affect the phenotype in relation to the environment and other epi genetic mechanisms that play important roles in gene regu lation and in proteinomics.
